Pyridostigmine Bromide | Interleukin Related interleukin-related.com

Product Name :
Pyridostigmine Bromide

Search keywords :
Pyridostigmine (bromide)

drugId :
null

Target Vo:
Acetylcholinesterase

Target Vo Short Name :
AChE

Moa_Name:
Acetylcholinesterase inhibitors

First Approval Country :
United States

First Approval Date Filter:
1955

Origin Company_Name :
Valeant

Active Company_Name :
Alvogen Inc

Active Indication_Name:
Lambert-Eaton Myasthenic Syndrome

In Active Indication_Name:
Glycogen Storage Disease Type II

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ofatumumab Protocol
AIF (YP4062) Mouse mAb Epigenetics
BRD4 Antibody: BRD4 Antibody is an antibody about 152 kDa, targeting to BRD4.

Author: Interleukin Related

Related Posts